Dr. Myra Wilkerson

Dr. Myra WilkersonMYRA L. WILKERSON, M.D.
Anatomic and Clinical Pathology, Cytopathology
Chair, Division of Laboratory Medicine

100 North Academy Avenue
Danville, PA 17822-1920
1 800 695 6491

Dr. Wilkerson is the Chair of the Division of Laboratory Medicine for the Geisinger Health System.


Education:

She received her M.D. from Marshall University School of Medicine in Huntington, West Virginia. She completed her residency in anatomic and clinical pathology as well as a fellowship in cytopathology at Geisinger Medical Center in Danville, Pennsylvania.

Certifications:

Dr. Wilkerson is board-certified in anatomic and clinical pathology. Her area of specialization is genitourinary cytopathology.

Professional Affiliations:

Association for Pathology Informatics (API)
Association of Clinical Scientists (ACS); Fellow
College of American Pathologists (CAP); Fellow

Research interests:

Cryptorchidism, cervical cytology, informatics, and tissue microarrays.

Publications in Peer-Reviewed Journals:

Riff BP, Katona BW, Wilkerson M, Nathanson KL, Metz DC . HNPCC-associated pheochromocytoma: expanding the tumor spectrum. Pancreas 2015; 44(4); 676-678.

Henricks WH, Wilkerson ML, Castellani WJ, Whitsitt MS, Sinard JH. Pathologists as stewards of laboratory information. Arch Pathol Lab Med 2015; 139(3); 332-337.

Castellani WJ, Sinard JH, Wilkerson ML, Whitsitt MS, Henricks WH. Accreditation and regulatory implications of electronic health records for laboratory reporting. Arch Pathol Lab Med 2015; 139(3); 328-331.

Wilkerson ML, Henricks WH, Castellani WJ, Whitsitt MS, Sinard JH. Management of laboratory data and information exchange in the electronic health record. Arch Pathol Lab Med 2015; 139(3); 319-327.

Sinard JH, Castellani, Wilkerson ML, Henricks WG. Stand-alone laboratory information systems versus laboratory modules incorporated in the electronic health record. Arch Pathol Lab Med 2015; 139(3); 311-318.

Henricks WH, Wilkerson ML, Castellani WJ, Whitsitt MS, Sinard JH. Pathologists’ place in the electronic health record landscape. Arch Pathol Lab Med 2015; 139(3); 311-318.

Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med 2014; 138(12); 1643-1655.

Boctor FN, Wilkerson ML. Fresh frozen plasma as a source of cholesterol for newborn with Smith-Lemli-Opitz syndrome associated with defective cholesterol synthesis. Ann Clin Lab Sci 2014; 44(3); 332-333.

Wilkerson M, Liu H, Lin F, Cheng L. Genitourinary System (Urinary Bladder, Testis, Prostate and Kidney). Review article. Arch Pathol Lab Med 2014; 138(12); 1643-1665.

Liu H, Shi J, Wilkerson M, Yang XJ, Lin F. Immunohistochemical evaluation of ERG expression in various benign and malignant tissues. Ann Clin Lab Sci 2013; 43; 3-9.

Liu H, Shi J, Wilkerson ML, Lin F . Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues – a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012; 138; 57-64.

Liu H, Shi J, Wang HL, Zhang J, Brown RE, Wilkerson M, Lin F. Expression of von Hippel-Lindau Gene Product (pVHL) and S100P in cystic neoplasms of the pancreas – with an implication for their roles in tumorigenesis. Ann Clin Lab Sci 2012; 42(2); 109-117.

Zhang PL, Wilkerson ML, Schworer CM. C4d staining is a valuable marker in identifying chronic GVHD in colonic biopsies following BMT. Bone Marrow Transplant 2008; 42; 209-211.

Prichard JW, Strevig G, Brown AM, Wilkerson M. Informatics tools for quality in anatomic pathology. Clin Lab Med 2008; 28; 207-222.

Walker RN, Murphy, TJ , Wilkerson ML . Testicular hamartomas in a patient with Bannayan-Riley-Ruvalcaba syndrome. J Ultrasound Med 2008; 27; 1245-1248.

Deng H, Shi J, Wilkerson M, Meschter S, Dupree W, Lin F. Usefulness of S100P in Diagnosis of Adenocarcinoma of Pancreas on Fine-Needle Aspiration Biopsy Specimens. Am J Clin Pathol 2008; 129; 81-88.

Shi J, Liu H, Wilkerson M, Huang Y, Meschter S, Dupree W, Schuerch C, Lin F. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol 2007; 38; 1335-1344.

Liu H, Shi J, Wilkerson M, Huang Y, Dupree W, Lin F. Immunohistochemical detection of p16 in liquid-based cytology specimens on cell block sections. Cancer Cytopathology 2007; 111; 74-82.

Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU,Prichard JW, Wilkerson M, Herbermann RB, Becich Mj, and the PCABC. A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform 2007; 3; 255-274.

Storm D, Redden T, Aguiar M, Wilkerson M, Jordan G, Sumfest J. Histologic evaluation of the testicular remnant associated with the vanishing testes syndrome: Is surgical management necessary. Urology 2007; 7; 1204-1206.

Other Publications:

Yu HE, Wilkerson M. Employee Engagement is vital for the Successful Selection of a Total Laboratory Automation System. Lab Med. 2017; https://doi.org/10.1093/labmed/lmx030: In press.

Spinosa JC, Arnaout R, Berman MA, Birdsong G, Boguski MS, Booker D, Carter A, Castellani W, Chen D, Chen P, Dash RC, de Baca M, Elevitch F, Gilbertson J, Harrison J, Henricks W, Kennedy M, Knapik C, Olson JE, Robb J, Routbort M, Rudolf JW, Simpson RW, Sinard J, Wilkerson M. CAP Pathology Resource Guide: Clinical Informatics. CAP Pathology Resource Guide. 2016; Clinical Informatics: Version 1.0 .

Chen ZE, Liu H, Wilkerson ML. Archives Applied – Evolving Practices of IHC in Breast, Genitourinary, Gastrointestinal, and Liver Pathology. College of American Pathologists. 2015; Online CME: Self-Assessment Module.

Abstracts, Posters, and Other Presentations:

Marshall KA, Kethireddy S, Brown AM, Prichard JW, Wilkerson ML. Crowdsourcing to Create Structured Data Sets for Quality Improvement. Presentation. AMIA Joint Summits on Translational Science, San Francisco, California, March 27-30, 2017.

Liu H, Wilkerson M, Lin F. NKX3.1 is the Most Sensitive Immunohistochemical Marker in Identifying Metastatic Prostatic Carcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Liu H, Wilkerson M, Lin F. Immunohistochemical Evaluation of NKX3.1 Expression in Prostatic Ductal Adenocarcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

Harrison HH, Adler M, Kimmich, D, Knowles-Tuchman M, Costello D, Nowack, R, Mika A, Rockwell S, Shaeffer L, Dorion P, Grifone T, Olson J, Tsang P, Wilkerson M, Yu E, and the Analytical QC Team. Use of Sigma-based QC to monitor hematology and coagulation testing in an expending, multi-instrument, multi-site, integrated healthcare system. Abstract. AACC Annual Meeting, Philadelphia PA, July 31-August 4, 2016.

Wilkerson ML. Preparing for the Future: Why you should be thinking automation now. Invited Panelist. 1. Roche SmartLab, Automation Panel Disussion, Washington, DC, October 1, 2015.

Wilkerson ML. 5 Forward-Thinking Principles for Choosing an IVD Vendor-Partner. Invited Speaker. Roche L2 LabLeaders Summit, Philadelphia, PA, June 24, 2015.

Wilkerson M. Man vs. Machine: New Method Validation. Course Director and Speaker. Geisinger Medical Laboratories, Wilkes-Barre and Danville, Pennsylvania, June-September 2014.

Harrison HH, Young D, Sargent D, Labarbera J, Fereck C, Fitt W, Kimmich D, Kremitske D, Lopatka M, Sharretts S, Smeal K, Dorion P, Rolston R, Wilkerson M, Yu E, Jones JB. Expansion of a Multisite, Advanced Analytical QC Program to include Prothrombin Time Testing using Sigma Statistics Based on Auto-Generated Peer Values. Poster. American Association for Clinical Chemistry Annual Meeting, Houston, TX, July 2013.

Wilkerson M. Proficiency Testing. Course Director and Speaker. Geisinger Medical Laboratories, Wilkes-Barre and Danville, Pennsylvania, May and June 2013.

Wilkerson M, Lin F, Shi J. SF-1 immunohistochemical expression in tumors. Abstract. United States and Canadian Academy of Pathology, Baltimore, Maryland, March 2-8, 2013.

Lin F, Shi J, Wilkerson M, Liu H. SALL4 and PAX8 expression in carcinomas from various organs. Poster Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Wilkerson M, Lin F, Shi J. SF-1 immunohistochemical expression in tumors. Presentation. USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Wilkerson ML. Promoting System Integration with Information Technology. Invited Speaker. Compass Group, Geisinger Health System, Danville, PA, September 19, 2012.

Liu H, Wilkerson M, Lin F. Identification of an effective immunohistochemical panel in differentiating seminal vesicles from prostatic adenocarcinoma. Poster Presentation. CAP Annual Meeting , San Diego, CA, September 9-12, 2012.

Wilkerson M. QAZoom update: A software tool for tracking cervical cytology workload and diagnostic rates by preparation type. Presentation. 132nd Annual Meeting, Association of Clinical Scientists, Mobile, Alabama, May 16-20, 2012.

Wilkerson M. Laboratory Medical Director Program. Course Director and Speaker. Geisinger Medical Laboratories, Wilkes-Barre and Danville, Pennsylvania, April 13 and 16, 2012.

Liu H, Shi J, Wilkerson M, Yang Ximing, Lin F. Evaluation of ERG expression in tumors from various organs. Poster presentation. USCAP Annual Meeting, Vancouver, Canada, March 17-23, 2012.

Lin F, Shi J, Wilkerson M, Liu H. Evaluation of GATA3 expression in tumors from various organs. Poster presentation. USCAP Annual Meeting, Vancouver, Canada, March 17-23, 2012.

Zhu S, Zhang K, Liu H, Wilkerson M, Lin F. Comparison of expression of Napsin A with polyclonal and monoclonal antibodies in tumors of various organs. Poster presentation. USCAP Annual Meeting, Vancouver, Canada, March 17-23, 2012.

Wilkerson M, Lin F, Shi J. NANOG Immunohistochemical Expression in Tumors. Abstract #1057. United States and Canadian College of Pathology, Vancouver, British Columiba, March 17-23, 2012.

Prichard JW, Wilkerson ML, Mullay S, Lin F. Simultaneous Monitoring of 236 Categories of Quality in Anatomic Pathology. Poster Presentation. CAP Annual Meeting, Grapevine, TX, September 11-14, 2011.

Wilkerson M. QAZoom: A software tool for tracking cervical cytology workload and diagnostic rates by preparation type. Presentation. 131st Annual Meeting, Association of Clinical Scientists, Louisville, Kentucky, May 18-20, 2011.

Wilkerson M, Shi J, Liu H, Prichard JW, Lin F. Reevaluation of Expression of SALL4 and PAX8 in Carcinomas from Various Organs. Abstract #972. United States and Canadian College of Pathology, San Antonio, Texas, February 26-March 11, 2011.

Zhang K, Liu H, Zhu S, Wilkerson M, Lin F. Expression of Napsin A in carcinomas from various organs. Poster Presentation. USCAP, San Antonio, Texas, February 26-March 40, 2011.

Lin F, Shi J, Wang HL, Wilkerson M, Liu H. Utility of pVHL, maspin, S100P and IMP3 in diagnosis of carcinomas from various organ. Poster #53. United States and Canadian Academy of Pathology, San Antonio, Texas, February 26-March 4, 2011.

Lin F, Wang HL, Wilkerson M, Liu H. Utility of pVHL, Maspin, S100P and IMP3 in Diagnosis of Carcinomas from Various Organs. Abstract #1557. United States and Canadian Academy of Pathology, San Antonio, Texas, February 26-March 4, 2011.

Lin F, Shi J, Wilkerson M, Liu H. Loss of or Reduced Expression of S100P in Invasive Urothelial Carcinoma – With an Implication of Its Role in Tumor Progression. Poster #67. College of American Pathologists, Chicago, Illinois, September 26 to 29, 2010.

Kaspar H, Lin F, Liu H, MD, Wilkerson M. The value of using p16 immunohistochemical staining in the diagnosis of the limited endocervical samples with tiny hypercellular columnar cell tissue fragments. Poster. USCAP Annual Meeting, Chicago, IL, October 2009.

Wilkerson M. Monitoring quality in anatomic pathology. Presentation. 129th Annual Meeting, Association of Clinical Scientists, Tampa, Florida, May 13-15, 2009.

Lin F, Liu H, Dorion RP, Zhang K, Pellitteri PK, Schuerch C, Wilkerson M, Meschter S. Comparison of clinicopathologic features, preoperative fine needle aspiration, and expression of immunohistochemical markers in thyroid papillary microcarcinoma and thyroid papillary carcinoma. Poster Presentation. USCAP Meeting, Boston, March 7-13, 2009.

Lin F, Sh Ji, Liu H, Wilkerson M, Meschter S. S100P, pVHL, CDX2 and mucicarmine are a panel of useful markers in distinguishing mucin-producing neoplasms of the pancreas from gastrointestinal contaminants. Platform presentation. American Society of Cytopatology, Florida, November 2008.

Miller M, Schworer CW, Brown RE, Prichard JW, Wilkerson M, Bonventre JV, Lin F, Zhang PL, Ramdas J. Identifying the Origin and Therapeutic Target in Wilms' Tumor. Abstract #1534. 21st Annual Meeting of the American Society of Pediatric Hematology/Oncology, Cincinnati, OH, May 15, 2008.

Wilkerson M. Development of a surgical pathology specimen tracking tool. Presentation. 128th Annual Meeting, Association of Clinical Scientists., Los Angeles, California, May 14-17, 2008.

Jianhui Shi, Liu H, Wilkerson M, Lin F. ProExC is a better immunohistochemical marker in differentiating between non-invasive low-grade and high-grade papillary urothelial carcinomas. Abstract. USCAP Meeting, Denver, CO, March 1-7, 2008.

Kurtinecz M, Van Dine D, Varma CR, Zhang PL, Meschter S, Wilkerson M, Kotru A, Dupree W, Lin F. Immunohistochemical Detection of BK Virus Infection in Urine Specimens on Cell Block Sections.. Presentation. American Society of Cytopathology Annual Meeting, Houston, TX, , November 2-6, 2007.

Lin F, Liu H, J Shi, Wilkerson M, Y Huang, Meschter S, Dupree W. Immunohistochemical Detection of p16/ProEXC on Screening Squamous Intraepithelial Lesions in Liquid-Based Cytology Specimens on Cell Block Sections. Presentation. American Society of Cytopathology Annual Meeting, Houston, TX, , November 2-6, 2007.

Boctor FN, Bucaloiu ID, Makary AZ, Friedenberg, Leberfinger D, Wilkerson M, Jeffreys W. Utilization of therapeutic plasma exchange in the treatment of two unusual neurologic diseases . Presentation. Association of Clinical Scientists 127th meeting, Hershey, PA, May 16-20, 2007.

Wilkerson M. Atypical cells in body cavity fluids: an algorithmic approach to diagnosis. Abstract and podium presentation. Association of Clinical Scientists Annual Meeting, Harrisburg, PA , May 16-19, 2007.

Boctor FN, Leberfinger D, Wilkerson M, Jeffreys W. Long term plasma apheresis of acquired neuromyotonia (Isaacs’ syndrome). Presentation. American Society for Apheresis 21st annual meeting, Nashville, TN, April 18-21, 2007.

Shi J, Liu H,Wilkerson M, Meschter S, Dupree W, Lin F. Evaluation of p16, MCM 2, DNA Topoisomerase IIA, and ProEXC in Cervical Squamous Intraepithelial Lesions. Abstract. United States and Canadian Academy of Pathology 96th Annual Meeting, San Diego, CA, March 24-30, 2007.

Deng H, Shi J, Meschter S, Wilkerson M, Dupree W, Lin F. Utility of S100P in Diagnosis of Adenocarcinoma of the Pancreas on Fine Needle Aspiration Biopsy Specimens. Platform Presentation. United States and Canadian Academy of Pathology 96th Annual Meeting, San Diego, CA, March 24-30, 2007.

Liu H, SHi J, Wilkerson M, Meschter S, Wilkerson M, Dupree W, Lin F. Immunodetection of Squamous Intraepithelial Lesions Using a Cocktail of p16 and ProEXC in Liquid-Based Cytology Specimens on Cell Block Sections. Platform presentation. United States and Canadian Academy of Pathology 96th Annual Meeting, San Diego, California, March 24-30, 2007.

Textbook Chapters

Liu H, Wilkerson M, Lin F. Thyroid, parathyroid, and adrenal gland. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. New York: Springer; 2015; 285-286 .

Wilkerson M, Cheng L. Urinary Bladder and Urachus. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. New York: Springer; 2015; 421-438 .

Wilkerson M, Cheng L. Testis and paratesticular tissue. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. New York: Springer; 2015; 465-480 .

Wilkerson M, Hewitt S. Tissue Microarray. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. New York: Springer; 2015; 105-118 .

Lin F, Prichard J, Bitting A, Shi J, Liu H, Wilkerson M, Chen Z. Geisinger immunohistochemical antibodies and staining protocols. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. 2nd ed.. Lin F, Prichard JW, Liu H, Wilkeson M, Chen ZM, eds. New York: Springer; 2015; 39-56 .

Wilkerson ML, Powell E. Tissue Microarray. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. Lin F, Prichard JW, eds. New York: Springer; 2011; 45-54 .

Prichard JW, Liu H, Wilkerson ML. Ovary. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. Lin F, Prichard JW, eds. New York: Springer; 2011; 277-298 .

Wilkerson ML. Urinary Bladder. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. Lin F, Prichard JW, eds. New York: Springer; 2011; 321-333 .

Wilkerson ML. Testis and Paratesticular Tissue. In Handbook of Practical Immunohistochemistry: Frequently Asked Questions. Lin F, Prichard JW, eds. New York: Springer; 2011; 355-366 .

Locations  |    Search  |    Site Map |   Contact Us

©2000-2016 Geisinger Health System.   All rights reserved.